Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
INVO Fertility ( (IVF) ) has provided an update.
On September 8, 2025, INVO Fertility, Inc. saw an institutional investor exercise its Additional Investment Right to acquire 200 shares of Series C-2 Convertible Preferred Stock for $200,000. This transaction adjusted the conversion price to $0.7362 per share and was executed without registration under the Securities Act, relying on exemptions for non-public offerings.
The most recent analyst rating on (IVF) stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on INVO Fertility stock, see the IVF Stock Forecast page.
Spark’s Take on IVF Stock
According to Spark, TipRanks’ AI Analyst, IVF is a Underperform.
The overall stock score is primarily impacted by poor financial performance and bearish technical indicators. The company’s significant operational losses and high leverage pose substantial risks. The negative P/E ratio and lack of dividend yield further weaken the valuation. Despite a positive corporate event, the overall outlook remains challenging.
To see Spark’s full report on IVF stock, click here.
More about INVO Fertility
Average Trading Volume: 1,589,876
Technical Sentiment Signal: Sell
Current Market Cap: $4.45M
See more data about IVF stock on TipRanks’ Stock Analysis page.